Antibiotic duration and changes in FEV1 are not associated with time until next exacerbation in adult cystic fibrosis: a single center study

Abstract Background Pulmonary exacerbations (PEx) are a major driver of morbidity and mortality in cystic fibrosis and reducing their frequency by extending the time between them is an important therapeutic goal. Although treatment decisions for exacerbations are often made based on dynamic changes...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Julia C. Espel, Hannah L. Palac, Joanne F. Cullina, Alexandria P. Clarke, Susanna A. McColley, Michelle H. Prickett, Manu Jain
Format: Artigo
Jezik:Inglês
Izdano: BMC 2017-11-01
Serija:BMC Pulmonary Medicine
Teme:
Antibiotics
Bronchiectasis
Cystic fibrosis
Exacerbation
Outcomes Pseudomonas aeruginosa
Online dostop:http://link.springer.com/article/10.1186/s12890-017-0503-6
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki